---
figid: PMC6695538__WJCC-7-1937-g001
figlink: /pmc/articles/PMC6695538/figure/F1/
number: F1
caption: 'The crosstalk between estrogen receptor and growth factor receptor intracellular
  signaling pathways. Growth factor receptors (GFRs) activate the downstream PI3K/AKT/mTOR
  signaling pathway and the Cyclin D1/CDK4/6 complex, while the ER-E2 complex has
  the same effect[]. The Cyclin D1/CDK4/6 complex drives cell proliferation by inducing
  Rb phosphorylation and promotes cell cycle from G1 phase to S phase in the nucleus[].
  Targeted agents against the CDK4/6 pathway and the PI3K/AKT/mTOR pathway can trigger
  cell cycle arrest and control tumor progression. ER: Estrogen receptor; GFR: Growth
  factor receptor; CDK4/6: Cyclin-dependent kinase; PI3K: Phosphatidylinositol 3-kinase;
  PIP2: Phosphatidylinositol 4,5-biphosphate; PIP3: Phosphatidylinositol triphosphate;
  mTOR: Mammalian target of rapamycin; Rb: Retinoblastoma protein.'
pmcid: PMC6695538
papertitle: 'Neoadjuvant endocrine therapy: A potential strategy for ER-positive breast
  cancer.'
reftext: Li-Tong Yao, et al. World J Clin Cases. 2019 Aug 6;7(15):1937-1953.
pmc_ranked_result_index: '3500'
pathway_score: 0.9451809
filename: WJCC-7-1937-g001.jpg
figtitle: The crosstalk between estrogen receptor and growth factor receptor intracellular
  signaling pathways
year: '2019'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6695538__WJCC-7-1937-g001.html
  '@type': Dataset
  description: 'The crosstalk between estrogen receptor and growth factor receptor
    intracellular signaling pathways. Growth factor receptors (GFRs) activate the
    downstream PI3K/AKT/mTOR signaling pathway and the Cyclin D1/CDK4/6 complex, while
    the ER-E2 complex has the same effect[]. The Cyclin D1/CDK4/6 complex drives cell
    proliferation by inducing Rb phosphorylation and promotes cell cycle from G1 phase
    to S phase in the nucleus[]. Targeted agents against the CDK4/6 pathway and the
    PI3K/AKT/mTOR pathway can trigger cell cycle arrest and control tumor progression.
    ER: Estrogen receptor; GFR: Growth factor receptor; CDK4/6: Cyclin-dependent kinase;
    PI3K: Phosphatidylinositol 3-kinase; PIP2: Phosphatidylinositol 4,5-biphosphate;
    PIP3: Phosphatidylinositol triphosphate; mTOR: Mammalian target of rapamycin;
    Rb: Retinoblastoma protein.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - CDK6
  - CDK4
  - AKT2
  - AKT1
  - AKT3
  - MTOR
  - CCND1
  - RAPGEF5
  - Everolimus
genes:
- word: CDK4/6
  symbol: CDK6
  source: hgnc_symbol
  hgnc_symbol: CDK6
  entrez: '1021'
- word: CDK4/6
  symbol: CDK4
  source: hgnc_symbol
  hgnc_symbol: CDK4
  entrez: '1019'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: CyclinD1
  symbol: Cyclin-D1
  source: bioentities_symbol
  hgnc_symbol: CCND1
  entrez: '595'
- word: GFR
  symbol: GFR
  source: hgnc_alias_symbol
  hgnc_symbol: RAPGEF5
  entrez: '9771'
chemicals:
- word: Everolimus
  source: MESH
  identifier: C107135
diseases: []
figid_alias: PMC6695538__F1
redirect_from: /figures/PMC6695538__F1
figtype: Figure
---
